Chris Chun-Yiu Chan

1.2k total citations
8 papers, 226 citations indexed

About

Chris Chun-Yiu Chan is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chris Chun-Yiu Chan has authored 8 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chris Chun-Yiu Chan's work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Viral Infections and Vectors (2 papers). Chris Chun-Yiu Chan is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Viral Infections and Vectors (2 papers). Chris Chun-Yiu Chan collaborates with scholars based in Hong Kong and China. Chris Chun-Yiu Chan's co-authors include Jasper Fuk‐Woo Chan, Kwok‐Yung Yuen, Shuofeng Yuan, Hin Chu, Jian‐Piao Cai, Dong‐Yan Jin, Jianli Cao, Zi‐Wei Ye, Kaiming Tang and Ronghui Liang and has published in prestigious journals such as Nature Communications, Pharmacological Research and Viruses.

In The Last Decade

Chris Chun-Yiu Chan

8 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Chun-Yiu Chan Hong Kong 8 145 56 38 37 31 8 226
Ayesha Baig Germany 4 221 1.5× 61 1.1× 47 1.2× 40 1.1× 25 0.8× 8 336
Shweta Birla India 9 94 0.6× 110 2.0× 19 0.5× 27 0.7× 27 0.9× 22 294
Youvika Singh Brazil 4 210 1.4× 55 1.0× 78 2.1× 33 0.9× 20 0.6× 7 303
Rui Costa Germany 10 106 0.7× 68 1.2× 11 0.3× 28 0.8× 81 2.6× 13 256
Lalu Muhammad Irham Indonesia 9 69 0.5× 96 1.7× 15 0.4× 35 0.9× 37 1.2× 74 275
Chandani Sen United States 7 180 1.2× 112 2.0× 44 1.2× 56 1.5× 60 1.9× 13 366
Md. Abdullah‐Al‐Kamran Khan Bangladesh 9 181 1.2× 175 3.1× 38 1.0× 110 3.0× 42 1.4× 23 415
Courtney J. Mycroft‐West United Kingdom 9 87 0.6× 69 1.2× 17 0.4× 24 0.6× 40 1.3× 14 229
Brigitte von Brunn Germany 7 251 1.7× 140 2.5× 48 1.3× 82 2.2× 31 1.0× 9 405
Marissa L. Maciej-Hulme Netherlands 7 123 0.8× 69 1.2× 70 1.8× 40 1.1× 61 2.0× 15 296

Countries citing papers authored by Chris Chun-Yiu Chan

Since Specialization
Citations

This map shows the geographic impact of Chris Chun-Yiu Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Chun-Yiu Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Chun-Yiu Chan more than expected).

Fields of papers citing papers by Chris Chun-Yiu Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Chun-Yiu Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Chun-Yiu Chan. The network helps show where Chris Chun-Yiu Chan may publish in the future.

Co-authorship network of co-authors of Chris Chun-Yiu Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Chun-Yiu Chan. A scholar is included among the top collaborators of Chris Chun-Yiu Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Chun-Yiu Chan. Chris Chun-Yiu Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Qiao, Wei, Vincent Kwok‐Man Poon, Chris Chung‐Sing Chan, et al.. (2022). SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nature Communications. 13(1). 44 indexed citations
2.
Wen, Lei, Kaiming Tang, Kenn Ka‐Heng Chik, et al.. (2021). In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor. International Journal of Biological Sciences. 17(6). 1555–1564. 11 indexed citations
3.
Cao, Jianli, Gang Lu, Lei Wen, et al.. (2021). Severe fever with thrombocytopenia syndrome virus (SFTSV)-host interactome screen identifies viral nucleoprotein-associated host factors as potential antiviral targets. Computational and Structural Biotechnology Journal. 19. 5568–5577. 9 indexed citations
4.
Ye, Zi‐Wei, Shuofeng Yuan, Jasper Fuk‐Woo Chan, et al.. (2021). Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Emerging Microbes & Infections. 10(1). 291–304. 38 indexed citations
5.
Yuan, Shuofeng, Jasper Fuk‐Woo Chan, Chris Chun-Yiu Chan, et al.. (2020). Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacological Research. 159. 104960–104960. 47 indexed citations
6.
Zou, Zijiao, Jessica Oi‐Ling Tsang, Bingpeng Yan, et al.. (2020). Metabolic Profiling Reveals Significant Perturbations of Intracellular Glucose Homeostasis in Enterovirus-Infected Cells. Metabolites. 10(8). 302–302. 12 indexed citations
7.
Yuan, Shuofeng, Chris Chun-Yiu Chan, Ronghui Liang, et al.. (2020). Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19). Viruses. 12(6). 628–628. 47 indexed citations
8.
Yuan, Shuofeng, Jasper Fuk‐Woo Chan, Zi‐Wei Ye, et al.. (2019). Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome Virus. Viruses. 11(4). 385–385. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026